🇺🇸·20h agoResearch
Reply to: "Chemoradiotherapy in Pancreatic Cancer: Toward Precision Oncology," "Key Methodological Considerations in the Interpretation of the CONKO-007 Trial," and "Chemoradiotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer"
Publisher
P
PubMed Journal of Clinical Oncology RSS
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on pubmed.ncbi.nlm.nih.gov
Leave the platform to read the original full article on the publisher site.
Source: PubMed Journal of Clinical Oncology RSS
Scope: Research
Related coverage
More related coverage
The Lancet·2h ago
[Editorial] Childhood cancer: progress, but not enough
The Lancet·2h ago
[Comment] Childhood cancer: an equity test for global health
The Lancet·2h ago
[Comment] Offline: The scandal of missing mothers
The Lancet·2h ago